Literature DB >> 26925208

Isothiazolo[4,3-b]pyridines as inhibitors of cyclin G associated kinase : synthesis, structure-activity relationship studies and antiviral activity.

Jiahong Li1, Sona Kovackova1, Szuyuan Pu2, Jef Rozenski3, Steven De Jonghe1, Shirit Einav2, Piet Herdewijn1.   

Abstract

Isothiazolo[4,3-b]pyridines are known to be endowed with potent affinity for cyclin G associated kinase (GAK). In this paper, we expanded the structure-activity relationship study by broadening the structural variety at position 3 of the isothiazolo[4,3-b]pyridine scaffold. The most potent GAK ligands (displaying Kd values of less than 100 nM) within this series carry an alkoxy group at position 3 of the central scaffold. Unfortunately, these ligands display only modest antiviral activity against the hepatitis C virus.

Entities:  

Year:  2015        PMID: 26925208      PMCID: PMC4763718          DOI: 10.1039/c5md00229j

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  22 in total

Review 1.  Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.

Authors:  Thomas von Hahn; Sandra Ciesek; Michael P Manns
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

2.  Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.

Authors:  Ann D Kwong; Robert S Kauffman; Patricia Hurter; Peter Mueller
Journal:  Nat Biotechnol       Date:  2011-11-08       Impact factor: 54.908

Review 3.  Cyclophilin inhibition as potential therapy for liver diseases.

Authors:  Nikolai V Naoumov
Journal:  J Hepatol       Date:  2014-07-15       Impact factor: 25.083

Review 4.  Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections.

Authors:  Srikanth Venkatraman
Journal:  Trends Pharmacol Sci       Date:  2012-04-19       Impact factor: 14.819

5.  Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.

Authors:  Abhay P S Rathore; Prasad N Paradkar; Satoru Watanabe; Kah Hin Tan; Cynthia Sung; John E Connolly; Jenny Low; Eng Eong Ooi; Subhash G Vasudevan
Journal:  Antiviral Res       Date:  2011-10-12       Impact factor: 5.970

6.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Authors:  Andrew W Tai; Yair Benita; Lee F Peng; Sun-Suk Kim; Naoya Sakamoto; Ramnik J Xavier; Raymond T Chung
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

7.  Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.

Authors:  Teresa I Ng; Hongmei Mo; Tami Pilot-Matias; Yupeng He; Gennadiy Koev; Preethi Krishnan; Rubina Mondal; Ron Pithawalla; Wenping He; Tanya Dekhtyar; Jeremy Packer; Mark Schurdak; Akhteruzzaman Molla
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

8.  AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.

Authors:  Gregory Neveu; Amotz Ziv-Av; Rina Barouch-Bentov; Elena Berkerman; Jon Mulholland; Shirit Einav
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

9.  Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.

Authors:  Gregory Neveu; Rina Barouch-Bentov; Amotz Ziv-Av; Doron Gerber; Yves Jacob; Shirit Einav
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

10.  Chronic hepatitis C virus (HCV) disease burden and cost in the United States.

Authors:  Homie Razavi; Antoine C Elkhoury; Elamin Elbasha; Chris Estes; Ken Pasini; Thierry Poynard; Ritesh Kumar
Journal:  Hepatology       Date:  2013-05-06       Impact factor: 17.425

View more
  4 in total

1.  Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.

Authors:  Szu-Yuan Pu; Randy Wouters; Stanford Schor; Jef Rozenski; Rina Barouch-Bentov; Laura I Prugar; Cecilia M O'Brien; Jennifer M Brannan; John M Dye; Piet Herdewijn; Steven De Jonghe; Shirit Einav
Journal:  J Med Chem       Date:  2018-07-16       Impact factor: 7.446

2.  Clathrin heavy chain phosphorylated at T606 plays a role in proper cell division.

Authors:  Yusuke Yabuno; Toshihiro Uchihashi; Towa Sasakura; Hiroyuki Shimizu; Yoko Naito; Kohshiro Fukushima; Kaori Ota; Mikihiko Kogo; Hiroshi Nojima; Norikazu Yabuta
Journal:  Cell Cycle       Date:  2019-07-04       Impact factor: 4.534

Review 3.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

Review 4.  Medicinal chemistry strategies toward host targeting antiviral agents.

Authors:  Xingyue Ji; Zhuorong Li
Journal:  Med Res Rev       Date:  2020-02-14       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.